Publicaciones en colaboración con investigadores/as de University of North Carolina at Chapel Hill (2)

2014

  1. Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy

    Journal of the National Cancer Institute, Vol. 106, Núm. 11

2012

  1. PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition

    Cancer Discovery, Vol. 2, Núm. 11, pp. 1036-1047